Diakonhjemmet hospital receives around 30 million for research from Health South-East
The board of Helse Sør-Est RHF has approved the allocation of regional research funds for 2025. The sum is NOK 149 million for a total of 86 research projects. A significant part of this goes to Diakonhjemmet hospital and projects in the REMEDY portfolio. In the picture, you see three of them who are happy to receive funding for research, PhD scholarship holder Camilla Fongen, senior physician Birgitte Nellemann and professor Sella Provan.
The allocation also includes strategic funds for non-university hospitals and funds for priority areas. This year, four projects have been awarded in the thematically open call, while three of the projects have received funding in the priority areas category.
- It is gratifying that so many good research projects at the hospital have received funding from Helse Sør-East, says head of research at Diakonhjemmet hospital, Espen A. Haavardsholm.
He believes this is an expression that the high level of research activity at the hospital is of good quality.
For many years, the hospital has had the greatest research activity among Norwegian hospitals without university status.
- This award contributes to us being able to carry out planned research projects in the best interests of the patients, says Haavardsholm.
The projects at Diakonhjemmet hospital that have received funding are:
- Ragne Gunnarsdatter Hole: NORWORK | 682,000/ 6 years (50%)
- Ida Kristine Bos-Haugen: PICASSO | 1,136,000/ 3 years
- Ingrid Jyssum: RA-DRUM | 682,000/ 6 years (50%)
- Sella Aarrestad Provan: TODAY | 682,000/ 6 years (50%)
- Espen Molden: Biomarkers of clozapine toxicity in patients with resistant schizophrenia | 1,363,000/ 3 years
- Nina Østerås: RemMonitJia | 3,000,000/ 3 years
- Birgitte Nellemann: SPARK | 1,039,000/ 3 years
Click on the projects that have links to read more about them!
